Wordt geladen...
Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
Clostridioides difficile infection (CDI) is a major cause of nosocomial diarrhea that is deemed a global health threat. C. difficile strain BI/NAP1/027 has contributed to the increase in the mortality, severity of CDI outbreaks and recurrence rates (rCDI). Updated CDI treatment guidelines suggest va...
Bewaard in:
| Gepubliceerd in: | J Exp Pharmacol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7553590/ https://ncbi.nlm.nih.gov/pubmed/33116952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S242959 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|